Using kinematic theory to help diagnose Parkinson's disease
Official title: Contribution of the Kinematic Theory in the Early Differential Diagnosis of the Parkinson's Disease
Run by Centre hospitalier de l'Université de Montréal (CHUM) · NCT06161636 · Data updated 2026-11-12
This study is testing new ways to use movement analysis to help tell the difference between people with Parkinson's disease, related conditions, and healthy individuals.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 50 Years to 75 Years |
| Sex | All |
| Enrollment | 90 (estimated) |
| Sponsor | Centre hospitalier de l'Université de Montréal (CHUM) Academic / other |
| Locations | 1 site (Montreal, Quebec) |
| Status | Recruiting |
| Started | February 19, 2020 |
| Main results expected | December 2028 |
| Study ends | December 2028 |
| Registry record updated | February 14, 2025 |
| Trial ID | NCT06161636 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals aged 50-75 diagnosed with Parkinsonism for 6 years or less, as well as healthy volunteers without neurological history.
✕Probably not a fit
Patients with major neurocognitive disorders or other significant neurological conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to differentiate between patients with Parkinson's disease, related syndromes, and healthy individuals using advanced kinematic analysis. It will employ various non-invasive techniques, including oculovisual measurements, to assess motor performance and identify potential biomarkers for clinical diagnosis. The study will compare the reliability of different parametric approaches in distinguishing these groups, focusing on the early stages of Parkinsonism. While it has strengths in its innovative methodology, it acknowledges limitations due to the absence of multimodal confirmation methods.
Why it matters
Potential benefit: If successful, this study could enhance early diagnosis and differentiation of Parkinson's disease, leading to better-targeted treatments.
How similar studies have gone: While this approach is innovative, similar studies have shown promise in using non-invasive techniques for diagnosing Parkinson's disease.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Being diagnosed with Parkinsonism including idiopathic Parkinson's disease or a related syndrome; * Have motor symptoms of Parkinsonism for 6 years or less; * Be a healthy volunteer subject in good general health with no prior neurological history; * Age between 50-75 years old; * If applicable, be able to safely leave home in the morning without having taken antiparkinsonian medication for the past 12 hours. Exclusion Criteria: * Major neurocognitive disorders; * History of other neurological conditions, such as ischemic or hemorrhagic stroke, paralysis of a limb, traumatic brain injury, epilepsy, orofacial dystonia, essential tremor; * History of oromandibular or laryngeal procedures; * Uncorrected deafness; * Any contraindication to pupillary dilation.
Where it's running
-
CHUM/Université de Montréal
Montreal, Quebec, Canada Recruiting
Study contacts
- Principal investigator: Pierre Blanchet — CHUM/Université de Montréal
- Study coordinator: Pierre Blanchet, MD
- Email: pierre.j.blanchet@umontreal.ca
- Phone: 514-890-8123
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Tributyrin for PSP: a virtual, early-phase study
This study tests whether tributyrin is safe and tolerable in people with Progressive Supranuclear Palsy who are 45 or older, using virtual visits.
-
A look at why Lewy body conditions cause visual hallucinations
This study tests brain‑imaging in people with Lewy body diseases who do or don’t experience visual hallucinations, and in healthy volunteers, to see how brain networks might create these images.
-
How physical activity might help people with Parkinson’s disease who have DBS-STN implants
This study tests whether adding regular physical activity can help people with Parkinson’s who have DBS-STN stimulation by trying a structured physiotherapy approach alongside standard care.
-
Can hippotherapy improve mobility, gait, balance, and quality of life in people with Parkinson's disease?
This pilot trial tests whether adding horse-assisted therapy to standard rehab helps mobility, gait, balance, and perceived health in adults with Parkinson's disease.
-
Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns
This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.